🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Multiple Myeloma of Bone

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545n/a142 sites📍 Birmingham📍 Gilbert📍 Phoenix Center for International Blood and Marrow Transplant Resear… · Tests: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome NCT02269592n/a7 sites📍 Boston📍 Brighton📍 Methuen Dana-Farber Cancer Institute Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care NCT05745285NA3 sites📍 Miami📍 Chicago📍 San Antonio University of Miami · Tests: LLS Program Personalized NK Cell Therapy in CBT NCT02727803Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin, Busulfan, Clofarabine, Cyclophosphamide Allo HSCT Using RIC and PTCy for Hematological Diseases NCT05805605Phase 21 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: Peripheral Blood Stem Cell Transplant, Allopurinol 300 MG, Fludarabine, Cyclophosphamide, Bone Marrow Cell Transplant High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) NCT07205523n/a1 site📍 Xining Yigeng Cao,MD,PhD The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen NCT01890486n/a1 site📍 Winston-Salem Wake Forest University Health Sciences Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization NCT04211259EARLY Phase 12 sites📍 New Brunswick📍 New Brunswick Rutgers, The State University of New Jersey · Tests: Loratadine, Placebo, Questionnaire Administration Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma. NCT04533217NA1 site📍 Middelfart Spine Centre of Southern Denmark · Tests: Vertebroplasty INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) NCT07403630NA2 sites📍 Palermo📍 Perugia Azienda Ospedaliero-Universitaria di Parma · Tests: Functional tests, Multi-omics analyses, Cytogenetics/ FISH Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma NCT03858205NA9 sites📍 Duarte📍 Los Angeles📍 Los Angeles University of Southern California · Tests: Quality-of-Life Assessment, Questionnaire Administration, Radiation Therapy Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation NCT04935684Phase 220 sites📍 Amiens📍 Angers📍 Besançon University Hospital, Clermont-Ferrand · Tests: Fecal Microbiota Transplantation Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders NCT03314974Phase 21 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: HSCT with TBI Regimen, HSCT with Non-TBI Regimen Registry of Older Patients With Cancer NCT01137825n/a7 sites📍 Boone📍 Chapel Hill📍 Greenville UNC Lineberger Comprehensive Cancer Center Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study NCT07514052n/a1 site📍 Taiyuan Shanxi Bethune Hospital · Tests: Selinexor-Based Regimen Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution NCT07214324n/a4 sites📍 Bologna📍 Catania📍 Palermo Azienda USL Reggio Emilia - IRCCS · Tests: Collection of biological material Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT) NCT05444348NA7 sites📍 Aalborg📍 Aarhus📍 Esbjerg Christoffer Johansen · Tests: Advance consultation concerning your life and treatment (ACT ) Feasibility of a Multi-omics Platform for Hematological Malignancies NCT07445438NA1 site📍 Parma Azienda Ospedaliero-Universitaria di Parma · Tests: Multi-omics analyses, Functional tests Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. NCT04771572Phase 18 sites📍 Chicago📍 Boston📍 Chapel Hill Newave Pharmaceutical Inc · Tests: LP-118 At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer NCT05969860Phase 22 sites📍 Jacksonville📍 Grand Forks Mayo Clinic · Tests: Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment, Questionnaire Administration National Longitudinal Cohort of Hematological Diseases NCT04645199n/a1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China Collection of Tissue Samples for Cancer Research NCT00900198n/a17 sites📍 Sacramento📍 Aurora📍 Atlanta National Cancer Institute (NCI) · Tests: Biopsy "Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma NCT06988020NA1 site📍 Brussels Cliniques universitaires Saint-Luc- Université Catholique d… · Tests: MRI Prospective Cohort of Single-dose Radiotherapy for Painful Bone Lesions in Multiple Myeloma NCT05996367NA1 site📍 São Paulo Instituto do Cancer do Estado de São Paulo · Tests: Single-dose involved-site radiotherapy Cancer Experience Registry (CER) for Cancer Patients and Caregivers NCT02333604n/a1 site📍 Washington D.C. Cancer Support Community, Research and Training Institute, … Methods of T Cell Depletion Trial (MoTD) NCT04888741Phase 217 sites📍 Cardiff📍 Birmingham📍 Bristol University of Birmingham · Tests: Thymoglobulin, Cyclophosphamide, Cyclosporine, Sirolimus, Mycophenolate Mofetil The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas NCT07285044Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cancer Therapeutic Procedure, Cancer Therapeutic Procedure, Questionnaire Administration Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies NCT06904066Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: aldesleukin, cyclophosphamide, fludarabine phosphate, Individual Patient TCR-Transduced PBL, TruSight Oncology (TSO) 500 Early Detection and Screening of Hematological Malignancies - SANGUINE NCT05735704n/a4 sites📍 Olomouc📍 Athens📍 Tel Aviv JaxBio Ltd · Tests: Blood sampling for HemaChip screening/diagnostic testing
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy